Differential effect of calcium phosphate and calcium pyrophosphate on binding of matrix metalloproteinases to fibrin: Comparison to a fibrin-binding protease from inflammatory joint fluids

Clinical and Experimental Immunology

Volumn 136, Issue 1, 2004, Pages 176-187

  Makowski, G S ^a   Ramsby, M L ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Farmington Valley Arthr/R LLC   (United States)

Author keywords

Calcium phosphate; Inflammation; Matrix metalloproteinases; Synovial fluid

Indexed keywords

CALCIUM PHOSPHATE; CALCIUM PYROPHOSPHATE; COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTHRITIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTAL STRUCTURE; ELECTRICITY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SYNOVIAL FLUID;

ADULT; AGED; ARTHRITIS; CALCIUM PHOSPHATES; CALCIUM PYROPHOSPHATE; FEMALE; FIBRIN; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; SYNOVIAL FLUID;

EID: 1842611600     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02413.x     Document Type: Article

References (38)

1. Stetler-Stevenson WG, Aznavoorian S, Liotta LS. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol 1993; 9:541-73.
2. Woessner JF Jr. The family of matrix metalloproteinases. Ann NY Acad Sci 1994; 731:11-21.
3. Nagase H. Matrix metalloproteinases. In: Hooper NM, ed. Zinc metalloproteinases in health and disease. London, UK: Taylor & Francis, 1996:153-204.
4. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997; 378:151-60.
5. Makowski GS, Ramsby ML. Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway. Inflammation 1998; 22:287-305.
6. Willenbock F, Crabbe T, Slocombe PM et al. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry 1993; 32:4330-7.
7. 3. Cell 1996; 85:683-93.
8. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994; 370:61-5.
9. Makowski GS, Ramsby ML. Binding of latent matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate. Inflammation 1998; 22:599-617.
10. Makowski GS, Ramsby ML. Amorphous calcium phosphate-mediated binding of matrix metalloproteinase 9 to fibrin is inhibited by pyrophosphate and bisphosphonate. Inflammation 1998; 23:333-60.
11. Russell RGG. Metabolism of inorganic pyrophosphate (PPi). Arthritis Rheum 1976; 19:465-78.
12. Fleisch H, Neuman WF. Mechanisms of calcification, role of collagen, polyphosphates, and phosphatase. Am J Physiol 1961; 200:1296-300.
13. Halverson PB. Calcium crystal-associated diseases. Curr Opin Rheumatol 1996; 8:259-61.
14. Makowski GS, Ramsby ML. Calibrating gelatin zymograms with human gelatinase standards. Anal Biochem 1996; 236:353-6.
15. - production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Meth Enzymol 1984; 105:358-65.
16. Vartio T, Baumann M. Human gelatinase/type IV procollagenase is a regular plasma component. FEBS Lett 1989; 255:285-9.
17. Zucker S, Lysik RM, Gurfinkel M et al. Immunoassay of type IV collagenase/gelatinase (MMP-2) in human plasma. J Immunol Meth 1992; 148:189-98.
18. Fujisawa R, Wada Y, Nodaska Y, Kuboki Y. Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals. Biochim Biophys Acta 1996; 1292:53-60.
19. Bauer BJ. Affinity and stoichiometry of calcium binding by asenazo III. Anal Biochem 1981; 110:61-72.
20. Clauss A. Rapid physiological coagulation method for the determination of fibrinogen. Acta Haematol 1957; 17:237-46.
21. Regoeczi E. Occlusion of plasma proteins by human fibrin: studies using trace-labelled proteins. Br J Haematol 1968; 14:279-90.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
23. Makowski GS, Ramsby ML. pH modification to enhance the molecular seiving properties of sodium dodecyl sulfate-10% polyacrylamide gels. Anal Biochem 1993; 212:283-5.
24. Francis CW, Marder VJ, Barlow GH. Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure. J Clin Invest 1980; 66:1033-43.
25. Ryan LM, McCarty DJ. Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition. Ann Rheum Dis 1995; 54:939-41.
26. Rull M. Calcium crystal-associated diseases and miscellaneous crystals. Curr Opin Rheumatol 1997; 9:274-9.
27. Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo Y, Hoyland JA. Gene expression of matrix metalloproteinases 1,3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 1997; 56:542-9.
28. McCarthy GM, Marcius AM, Christopherson PA, Ryan LM, Pourmotabbed T. Basic calcium phosphate crystals induce synthesis and secretion of 92 kDa gelatinase (gelatinase B/matrix metalloproteinase 9) in human fibroblasts. Ann Rheum Dis 1998; 57:56-60.
29. Nalbant S, Martinez JAM, Kitumnuaypong T, Clayburne G, Sieck M, Scumacher HR. Synovial fluid features and their relations to osteroarthritis severity: new findings from sequential studies. Osteoarth Cartil 2003; 11:50-4.
30. Kremer EA, Chen Y, Sozuki K, Nagase H, Gorski JP. Hydroxyapatite induces autolytic degradation and inactivation of matrix metalloproteinase-1 and -3. J Bone Min Res 1998; 13:1890-902.
31. Mori S, Harruf R, Ambrosius W, Burr DB. Trabecular bone volume and microdamage in the femoral heads of women with and without femoral neck fractures. Bone 1997; 21:521-6.
32. Rakoczi I, Wiman B, Collen D. On the biological signficance of the specific interaction between fibrin, plasminogen, and antiplasmin. Biochim Biophys Acta 1978; 540:295-300.
33. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-9.
34. Weinberg JB, Pippen AMM, Greenberg CS. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991; 34:996-1005.
35. Reddi AH, Anderson WA. Collagenous bone matrix-induced endochondral ossification and hemopoiesis. J Cell Biol 1976; 69:557-72.
36. Brown LF, Dvorak AM, Dvorak HF. Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and many other types of disease. Am Rev Respir Dis 1989; 140:1104-7.
37. Cliffton DE, Agostino D. The effects of fibrin formation and alterations in the clotting mechanism on the development of metastases. Vasc Dis 1965; 2:43-52.
38. Mirashi M, Soria J, Lu H, Soria C, Samama M, Caen J-P. Defective thrombolysis due to collagen incorporation in fibrin clots. Thromb Res 1988; S8:73-80.